US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Design Therapeutics, Inc.

3.77

+0.09002.45%

Post-market: 3.770.00000.00%13:01 EDT

Volume:47.53K

Turnover:177.04K

Market Cap:214.02M

PE:-3.80

High:3.84

Open:3.75

Low:3.63

Close:3.68

Loading ...

Overview Company News Filings

Design Therapeutics Confirms Directors at Annual Meeting

Design Therapeutics Inc. Concluded Annual Stockholder Meeting

Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Johnson & Johnson (JNJ) and Design Therapeutics (DSGN)

RBC Capital Keeps Their Hold Rating on Design Therapeutics (DSGN)

Design Therapeutics announces first FA patient dosed in RESTORE-FA trial

Design Therapeutics Faces FDA Clinical Hold on IND Application for U.S. Expansion of RESTORE-FA Trial

Design Therapeutics Inc - FDA Places Clinical Hold on Ind Application for U.S. Sites

THOMSON REUTERS

Design Therapeutics Announces Start of Friedreich Ataxia Patient Dosing Ex-U.S. in Its Restore-Fa Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2

THOMSON REUTERS

Design Therapeutics Inc - No Adverse Events Reported in DT-216P2 Administration

THOMSON REUTERS

Design Therapeutics Inc - Phase 1 Single-Ascending Dose Trial Shows DT-216P2 Well-Tolerated

THOMSON REUTERS

Design Therapeutics Inc. Files Initial Beneficial Ownership Statement for Chris Storgard, Chief Medical Officer

Piper Sandler Sticks to Its Buy Rating for Design Therapeutics (DSGN)

BRIEF-Design Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million - SEC Filing

Design Therapeutics Inc Files for Mixed Shelf of up to $300 Mln - SEC Filing

THOMSON REUTERS

Design Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

BRIEF-Design Therapeutics Q1 Basic EPS USD -0.31

Design Therapeutics Q1 Operating Expenses USD 20.418 Million

THOMSON REUTERS

Press Release: Design Therapeutics Highlights Momentum Across Lead GeneTAC(R) Programs and Reports First Quarter 2025 Financial Results

Design Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview

Design Therapeutics Says Eye Drops for Fuchs Endothelial Corneal Dystrophy 'Well-Tolerated'

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/DSGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DSGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSGN\",,,,,undefined,":{"symbol":"DSGN","market":"US","secType":"STK","nameCN":"Design Therapeutics, Inc.","latestPrice":3.77,"timestamp":1751562000000,"preClose":3.68,"halted":0,"volume":47533,"hourTrading":{"tag":"盘后","latestPrice":3.77,"preClose":3.77,"latestTime":"13:01 EDT","volume":300,"amount":1131,"timestamp":1751562109357},"delay":0,"floatShares":25535567,"shares":56768678,"eps":-0.991942,"marketStatus":"Closed Independence Day","change":0.09,"latestTime":"07-03 13:00:00 EDT","open":3.75,"high":3.84,"low":3.63,"amount":177036.1801,"amplitude":0.057065,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.991942,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751875200000},"marketStatusCode":7,"adr":0,"listingDate":1616731200000,"exchange":"NASDAQ","adjPreClose":3.68,"postHourTrading":{"tag":"盘后","latestPrice":3.77,"preClose":3.77,"latestTime":"13:01 EDT","volume":300,"amount":1131,"timestamp":1751562109357},"volumeRatio":0.8190636834000058,"impliedVol":0.7265,"impliedVolPercentile":0.288},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSGN\",,,,,undefined,":{"symbol":"DSGN","floatShares":25535567,"roa":"-16.56%","roe":"-22.59%","lyrEps":-0.876312,"volumeRatio":0.8190636834000058,"shares":56768678,"dividePrice":0,"high":3.84,"amplitude":0.057065,"preClose":3.68,"low":3.63,"week52Low":2.6,"pbRate":"0.94","week52High":7.77,"institutionHeld":0,"latestPrice":3.77,"eps":-0.991942,"divideRate":0,"volume":47533,"delay":0,"ttmEps":-0.991942,"open":3.75,"prevYearClose":6.17,"prevWeekClose":3.57,"prevMonthClose":3.37,"prevQuarterClose":3.37,"fiveDayClose":3.82,"twentyDayClose":4.1,"sixtyDayClose":3.14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DSGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2543540980","title":"Design Therapeutics Confirms Directors at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543540980","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543540980?lang=en_us&edition=fundamental","pubTime":"2025-06-13 05:11","pubTimestamp":1749762713,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Design Therapeutics ( ($DSGN) ). On June 10, 2025, Design Therapeutics, Inc. held its 2025 Annual Meeting of St...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/design-therapeutics-confirms-directors-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/design-therapeutics-confirms-directors-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4505","BK4539","BK4007","DSGN","LENZ"],"gpt_icon":0},{"id":"2543422715","title":"Design Therapeutics Inc. Concluded Annual Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543422715","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543422715?lang=en_us&edition=fundamental","pubTime":"2025-06-13 04:20","pubTimestamp":1749759602,"startTime":"0","endTime":"0","summary":"Design Therapeutics Inc. held its 2025 Annual Meeting of Stockholders on June 10, 2025. During the meeting, stockholders elected Heather Berger, Ph.D., Rodney Lappe, Ph.D., and John Schmid as Class I Directors. Additionally, the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. Both proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Design Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2025, and is solely responsible for the information contained t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL7CtlPd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","BK4539","DSGN"],"gpt_icon":0},{"id":"2542080667","title":"Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Johnson & Johnson (JNJ) and Design Therapeutics (DSGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2542080667","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542080667?lang=en_us&edition=fundamental","pubTime":"2025-06-09 16:00","pubTimestamp":1749456059,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teva Pharmaceutical (TEVA – Research Report), Johnson & Johnson (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-teva-pharmaceutical-teva-johnson-johnson-jnj-and-design-therapeutics-dsgn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-teva-pharmaceutical-teva-johnson-johnson-jnj-and-design-therapeutics-dsgn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1894683264.USD","LU0792757196.USD","LU2430703095.HKD","BK4588","IE00B2B36J28.USD","IE00B3PB1722.GBP","LU2430703251.USD","LU1280957306.USD","LU1718418525.SGD","BK4533","IE00BFXG1179.USD","IE000M9KFDE8.USD","IE00BSNM7G36.USD","SG9999002224.SGD","LU1057294990.SGD","LU0114720955.EUR","LU0203345920.USD","LU2129689514.USD","DSGN","IE00BGHQF631.EUR","BK4505","IE00B4R5TH58.HKD","LU1059921491.USD","LU1585245621.USD","BK4137","LU2592432038.USD","IE00B3T34201.USD","LU1196500208.SGD","HCSG","LU1066053197.SGD","LU0795875169.SGD","LU1023059063.AUD","LU1267930813.SGD","LU1430594728.SGD","TEVA","BK4568","BK4550","LU1935042991.SGD","LU2505996509.AUD","LU0203347892.USD","LU0320765646.SGD","BK4007","JNJ","LU0985320562.USD","LU2129689605.HKD","SG9999001440.SGD","IE00BVYPNW00.USD","BK4532","LU1732799900.SGD","BK4584"],"gpt_icon":0},{"id":"2540067578","title":"RBC Capital Keeps Their Hold Rating on Design Therapeutics (DSGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540067578","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540067578?lang=en_us&edition=fundamental","pubTime":"2025-06-04 23:25","pubTimestamp":1749050732,"startTime":"0","endTime":"0","summary":"In a report released today, Leonid Timashev from RBC Capital reiterated a Hold rating on Design Therapeutics (DSGN – Research Report), with a price...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-hold-rating-on-design-therapeutics-dsgn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-hold-rating-on-design-therapeutics-dsgn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DSGN"],"gpt_icon":0},{"id":"2540068561","title":"Design Therapeutics announces first FA patient dosed in RESTORE-FA trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2540068561","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540068561?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:10","pubTimestamp":1749035428,"startTime":"0","endTime":"0","summary":"Design Therapeutics (DSGN) announced that the first Friedreich ataxia, FA, patient has been dosed via intravenous infusion in its RESTORE-FA open-l...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/design-therapeutics-announces-first-fa-patient-dosed-in-restore-fa-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/design-therapeutics-announces-first-fa-patient-dosed-in-restore-fa-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DSGN","BK4535","BK4139","BK4505","BK4130","FA","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2540504800","title":"Design Therapeutics Faces FDA Clinical Hold on IND Application for U.S. Expansion of RESTORE-FA Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2540504800","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540504800?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:00","pubTimestamp":1749034838,"startTime":"0","endTime":"0","summary":"Design Therapeutics Inc., a clinical-stage biotechnology firm focused on treating degenerative genetic diseases, announced the beginning of patient dosing in its RESTORE-FA Phase 1/2 multiple-ascending dose trial of DT-216P2 for Friedreich ataxia outside the United States. Initial data from a Phase 1 single-ascending dose trial in healthy volunteers indicated favorable safety and pharmacokinetics for DT-216P2. Design Therapeutics has submitted an investigational new drug  application to the U.S. FDA to expand the trial to U.S. sites. However, the FDA issued a clinical hold on the IND application, citing nonclinical deficiencies. The company intends to address these issues promptly to continue their development efforts in the U.S. The trial is currently open for enrollment in Australia, with data anticipated in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL88nCvB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LU2095319765.USD","DSGN","BK4139","IE00B64PRP62.GBP","LU2210150020.SGD","NDAQ","BK4505","IE00BKPKM429.USD","LU2210149790.SGD","IE00BGHQF748.EUR","BK4585","BK4588","BK4112","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2540481050","title":"Design Therapeutics Inc - FDA Places Clinical Hold on Ind Application for U.S. Sites","url":"https://stock-news.laohu8.com/highlight/detail?id=2540481050","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540481050?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:00","pubTimestamp":1749034801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nTUA8SY1NW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4505","DSGN","BK4139"],"gpt_icon":0},{"id":"2540050558","title":"Design Therapeutics Announces Start of Friedreich Ataxia Patient Dosing Ex-U.S. in Its Restore-Fa Phase 1/2 Multiple-Ascending Dose Trial of DT-216P2","url":"https://stock-news.laohu8.com/highlight/detail?id=2540050558","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540050558?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:00","pubTimestamp":1749034801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nTUA8SY1NW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DSGN","BK4539","BK4139","BK4505"],"gpt_icon":0},{"id":"2540050107","title":"Design Therapeutics Inc - No Adverse Events Reported in DT-216P2 Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2540050107","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540050107?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:00","pubTimestamp":1749034801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nTUA8SY1NW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DSGN","BK4505","BK4539"],"gpt_icon":0},{"id":"2540050104","title":"Design Therapeutics Inc - Phase 1 Single-Ascending Dose Trial Shows DT-216P2 Well-Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2540050104","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540050104?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:00","pubTimestamp":1749034801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nTUA8SY1NW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","BK4505","DSGN"],"gpt_icon":0},{"id":"2537015291","title":"Design Therapeutics Inc. Files Initial Beneficial Ownership Statement for Chris Storgard, Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2537015291","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537015291?lang=en_us&edition=fundamental","pubTime":"2025-05-24 04:35","pubTimestamp":1748032513,"startTime":"0","endTime":"0","summary":"Design Therapeutics Inc. has filed an initial statement of beneficial ownership. The filing lists Chris Storgard as the beneficial owner, serving as the Chief Medical Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Design Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 23, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL15VmLx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSGN","BK4539","BK4505","BK4139"],"gpt_icon":0},{"id":"2533881241","title":"Piper Sandler Sticks to Its Buy Rating for Design Therapeutics (DSGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533881241","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533881241?lang=en_us&edition=fundamental","pubTime":"2025-05-08 19:00","pubTimestamp":1746702034,"startTime":"0","endTime":"0","summary":"In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Design Therapeutics (DSGN – Research Report), with a price...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-design-therapeutics-dsgn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-design-therapeutics-dsgn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DSGN"],"gpt_icon":0},{"id":"2533967295","title":"BRIEF-Design Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2533967295","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533967295?lang=en_us&edition=fundamental","pubTime":"2025-05-08 05:20","pubTimestamp":1746652833,"startTime":"0","endTime":"0","summary":"BRIEF-Design Therapeutics Inc Files For Mixed Shelf Of Up To $300 Million - SEC FilingDesign Therapeutics Inc DSGN.O:DESIGN THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $300 MILLION - SEC FILINGSource text: [ID:n0001193125-25-114986]Further company coverage: DSGN.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nFWN3RF371:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","DSGN","BK4539"],"gpt_icon":0},{"id":"2533311962","title":"Design Therapeutics Inc Files for Mixed Shelf of up to $300 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2533311962","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533311962?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:54","pubTimestamp":1746651291,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nFWN3RF371:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DSGN","BK4505","BK4539"],"gpt_icon":0},{"id":"2533964274","title":"Design Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2533964274","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533964274?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:46","pubTimestamp":1746650790,"startTime":"0","endTime":"0","summary":"Design Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryDesign Therapeutics Inc DSGN.OQ reported a quarterly adjusted loss of 31 cents per share for the quarter ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nL8N3RF36F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSGN"],"gpt_icon":0},{"id":"2533966309","title":"BRIEF-Design Therapeutics Q1 Basic EPS USD -0.31","url":"https://stock-news.laohu8.com/highlight/detail?id=2533966309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533966309?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:01","pubTimestamp":1746648105,"startTime":"0","endTime":"0","summary":"BRIEF-Design Therapeutics Q1 Basic EPS USD -0.31\n\n\nMay 07 (Reuters) - Design Therapeutics Q1 net income USD -17.715 million.\n\nQ1 operating income USD -20.418 million\nQ1 operating expenses USD 20.418 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nPLX473362:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSGN"],"gpt_icon":0},{"id":"2533965031","title":"Design Therapeutics Q1 Operating Expenses USD 20.418 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533965031","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533965031?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:01","pubTimestamp":1746648060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250507:nPLX473362:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DSGN","BK4505","BK4539","BK4139"],"gpt_icon":0},{"id":"2533965057","title":"Press Release: Design Therapeutics Highlights Momentum Across Lead GeneTAC(R) Programs and Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533965057","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533965057?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:01","pubTimestamp":1746648060,"startTime":"0","endTime":"0","summary":"Design Therapeutics Highlights Momentum Across Lead GeneTAC Programs and Reports First Quarter 2025 Financial Results. Phase 1 Single Ascending Dose Trial of DT-216P2 for Friedreich Ataxia  Program Ongoing. Reported Favorable Phase 1 Data for DT-168 for Fuchs Endothelial Corneal Dystrophy  Program. Well-Capitalized with Cash and Securities of $229.7 Million to Fund Operations Through up to Four Potential Clinical Proof-of-Concept Data Sets. CARLSBAD, Calif., May 07, 2025  -- Design Therapeutics, Inc. , a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced progress across its portfolio of GeneTAC candidates and reported financial results for the first quarter 2025.corneal transplant surgery. Design plans to initiate the Pha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4181","BK4232","R","BK4022","BK4535","BK4505","BK4007","BK4539","DSGN","FA","PK","BK4130","BK4218","LENZ"],"gpt_icon":0},{"id":"2532817832","title":"Design Therapeutics Inc  expected to post a loss of 28 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2532817832","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532817832?lang=en_us&edition=fundamental","pubTime":"2025-05-02 19:19","pubTimestamp":1746184777,"startTime":"0","endTime":"0","summary":"Design Therapeutics Inc  expected to post a loss of28cents a share - Earnings Preview Design Therapeutics Inc DSGN.OQ DSGN.O is expected to show no change in quarterly revenue when it reports  results","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nL8N3RA1BE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSGN"],"gpt_icon":0},{"id":"2532888223","title":"Design Therapeutics Says Eye Drops for Fuchs Endothelial Corneal Dystrophy 'Well-Tolerated'","url":"https://stock-news.laohu8.com/highlight/detail?id=2532888223","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532888223?lang=en_us&edition=fundamental","pubTime":"2025-05-02 00:29","pubTimestamp":1746116981,"startTime":"0","endTime":"0","summary":"Design Therapeutics  said Thursday its experimental DT-168 eye drops to potentially treat Fuchs endothelial corneal dystrophy were well-tolerated in a phase 1 trial.The company said no serious side effects nor eye-related issues were reported. No treatment was discontinued due to adverse side effects, Design added.The company said it expects to begin a phase 2 biomarker trial in patients with Fuchs endothelial corneal dystrophy in H2, with results anticipated in 2026.The study will enroll FECD patients scheduled for corneal transplant surgery, the company added.Shares of the company were down 3.3% in recent trading.Price: 4.70, Change: -0.16, Percent Change: -3.29","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DSGN","BK4505","LENZ","BK4539","BK4139","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DSGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"DSGN","fiscalQuarterEnding":"2025/03","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2025-03-10","symbol":"DSGN","fiscalQuarterEnding":"2024/12","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"pre","actualEps":-0.24},{"market":"US","date":"2024-11-07","symbol":"DSGN","fiscalQuarterEnding":"2024/09","expectedEps":-0.26,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2024-08-05","symbol":"DSGN","fiscalQuarterEnding":"2024/06","expectedEps":-0.25,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"pre","actualEps":-0.21},{"market":"US","date":"2024-05-08","symbol":"DSGN","fiscalQuarterEnding":"2024/03","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DSGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DSGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.6667,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6667,"analysts":3,"updateTime":1715054400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DSGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DSGN","date":"2025-07-03","current":-3.808283,"percent":0.790066,"low":-266.429784,"twenty":-29.36429,"median":-6.658071,"eighty":-3.6782,"high":-1.499813,"avg":-22.110952,"sd":35.048786,"marketCap":214017916},"quantilePoints":[{"date":"2021-03-26","current":-266.429784,"twenty":-210.836408,"median":-127.446345,"eighty":-127.446345,"marketCap":2206038609},{"date":"2021-04-01","current":-197.50827,"twenty":-214.41814,"median":-197.50827,"eighty":-141.153339,"marketCap":1635368477},{"date":"2021-04-09","current":-176.59563,"twenty":-198.344776,"median":-196.080899,"eighty":-180.260321,"marketCap":1462211815},{"date":"2021-04-16","current":-156.014936,"twenty":-197.667604,"median":-194.919086,"eighty":-154.315369,"marketCap":1291803671},{"date":"2021-04-23","current":-127.932248,"twenty":-197.242713,"median":-162.554285,"eighty":-132.181165,"marketCap":1059279010},{"date":"2021-04-30","current":-174.139224,"twenty":-196.140649,"median":-157.342723,"eighty":-136.589417,"marketCap":1441872778},{"date":"2021-05-07","current":-186.222083,"twenty":-195.848536,"median":-170.952536,"eighty":-141.767785,"marketCap":1541918850},{"date":"2021-05-14","current":-96.369524,"twenty":-195.237755,"median":-157.342723,"eighty":-127.543526,"marketCap":1265428224},{"date":"2021-05-21","current":-114.100846,"twenty":-193.179685,"median":-153.62492,"eighty":-115.014659,"marketCap":1498258211},{"date":"2021-05-28","current":-109.825208,"twenty":-185.74408,"median":-150.6374,"eighty":-111.52708,"marketCap":1442114810},{"date":"2021-06-04","current":-109.950962,"twenty":-183.832067,"median":-141.741229,"eighty":-110.034798,"marketCap":1443766086},{"date":"2021-06-11","current":-113.555912,"twenty":-182.371502,"median":-128.861698,"eighty":-110.579733,"marketCap":1491102679},{"date":"2021-06-18","current":-107.813143,"twenty":-179.516761,"median":-127.446345,"eighty":-110.579733,"marketCap":1415694386},{"date":"2021-06-25","current":-98.423507,"twenty":-176.59563,"median":-117.223738,"eighty":-109.489864,"marketCap":1292399074},{"date":"2021-07-02","current":-81.153284,"twenty":-176.462851,"median":-115.567977,"eighty":-105.004636,"marketCap":1065623768},{"date":"2021-07-09","current":-77.757924,"twenty":-174.603949,"median":-114.561944,"eighty":-98.322904,"marketCap":1021039302},{"date":"2021-07-16","current":-74.404483,"twenty":-169.040523,"median":-113.828379,"eighty":-95.841357,"marketCap":977005262},{"date":"2021-07-23","current":-76.668056,"twenty":-165.26961,"median":-113.094814,"eighty":-89.595573,"marketCap":1006728239},{"date":"2021-07-30","current":-64.889093,"twenty":-158.803288,"median":-112.193576,"eighty":-80.013113,"marketCap":852058674},{"date":"2021-08-06","current":-64.134568,"twenty":-156.280493,"median":-110.789323,"eighty":-77.556718,"marketCap":842151015},{"date":"2021-08-13","current":-47.086374,"twenty":-154.315369,"median":-109.99288,"eighty":-75.217692,"marketCap":909944175},{"date":"2021-08-20","current":-42.665788,"twenty":-153.465586,"median":-109.489864,"eighty":-73.733794,"marketCap":824516345},{"date":"2021-08-27","current":-49.681686,"twenty":-152.828248,"median":-106.932865,"eighty":-66.507128,"marketCap":960098579},{"date":"2021-09-03","current":-50.480243,"twenty":-151.049014,"median":-103.747096,"eighty":-64.922627,"marketCap":975530703},{"date":"2021-09-10","current":-48.42681,"twenty":-145.379365,"median":-98.423507,"eighty":-59.380132,"marketCap":935848098},{"date":"2021-09-17","current":-46.116697,"twenty":-141.794341,"median":-96.87254,"eighty":-49.328039,"marketCap":891205167},{"date":"2021-09-24","current":-45.460739,"twenty":-137.87737,"median":-95.573082,"eighty":-48.392586,"marketCap":878528780},{"date":"2021-10-01","current":-42.751347,"twenty":-131.995275,"median":-92.21964,"eighty":-47.063558,"marketCap":826169787},{"date":"2021-10-08","current":-41.83871,"twenty":-128.675808,"median":-83.374939,"eighty":-46.116697,"marketCap":808533074},{"date":"2021-10-15","current":-40.640874,"twenty":-127.640706,"median":-79.686153,"eighty":-45.477851,"marketCap":785384888},{"date":"2021-10-22","current":-42.123909,"twenty":-127.446345,"median":-78.889711,"eighty":-45.021532,"marketCap":814044547},{"date":"2021-10-29","current":-44.719221,"twenty":-126.742046,"median":-76.709974,"eighty":-44.53099,"marketCap":864198950},{"date":"2021-11-05","current":-51.164721,"twenty":-121.710952,"median":-75.284761,"eighty":-44.593734,"marketCap":988758238},{"date":"2021-11-12","current":-39.021081,"twenty":-116.934504,"median":-74.383524,"eighty":-44.308534,"marketCap":1105194080},{"date":"2021-11-19","current":-39.996121,"twenty":-115.752416,"median":-72.727762,"eighty":-43.65828,"marketCap":1132810124},{"date":"2021-11-26","current":-34.672405,"twenty":-115.66858,"median":-68.913222,"eighty":-43.110698,"marketCap":982026524},{"date":"2021-12-03","current":-30.694244,"twenty":-115.517675,"median":-66.167592,"eighty":-42.819795,"marketCap":869353065},{"date":"2021-12-10","current":-34.204386,"twenty":-115.090111,"median":-64.931011,"eighty":-42.021238,"marketCap":968770823},{"date":"2021-12-17","current":-31.903293,"twenty":-114.427806,"median":-64.260322,"eighty":-41.678999,"marketCap":903596959},{"date":"2021-12-23","current":-35.822952,"twenty":-114.201449,"median":-51.891979,"eighty":-41.085785,"marketCap":1014613456},{"date":"2021-12-31","current":-41.751192,"twenty":-113.991859,"median":-50.622843,"eighty":-40.984623,"marketCap":1182519004},{"date":"2022-01-07","current":-35.04292,"twenty":-113.513994,"median":-49.938365,"eighty":-40.646578,"marketCap":992520621},{"date":"2022-01-14","current":-30.908752,"twenty":-113.29602,"median":-48.683489,"eighty":-39.742758,"marketCap":875428594},{"date":"2022-01-21","current":-21.782383,"twenty":-113.094814,"median":-48.42681,"eighty":-39.567103,"marketCap":616942422},{"date":"2022-01-28","current":-24.395488,"twenty":-112.256453,"median":-47.927711,"eighty":-38.74807,"marketCap":690953420},{"date":"2022-02-04","current":-24.844007,"twenty":-112.256453,"median":-47.428613,"eighty":-36.914996,"marketCap":703656801},{"date":"2022-02-11","current":-28.315147,"twenty":-112.130699,"median":-46.872474,"eighty":-36.193467,"marketCap":801969917},{"date":"2022-02-18","current":-26.930591,"twenty":-111.376175,"median":-46.116697,"eighty":-35.140424,"marketCap":762755135},{"date":"2022-02-25","current":-26.384569,"twenty":-110.906693,"median":-45.774458,"eighty":-34.672405,"marketCap":747290150},{"date":"2022-03-04","current":-29.875211,"twenty":-110.621651,"median":-45.474999,"eighty":-34.235588,"marketCap":846155588},{"date":"2022-03-11","current":-26.924006,"twenty":-110.143785,"median":-45.23258,"eighty":-33.798769,"marketCap":956690692},{"date":"2022-03-18","current":-30.685562,"twenty":-109.967729,"median":-44.990161,"eighty":-32.613122,"marketCap":1090350087},{"date":"2022-03-25","current":-25.815829,"twenty":-109.850359,"median":-44.605142,"eighty":-31.220765,"marketCap":917313858},{"date":"2022-04-01","current":-26.736708,"twenty":-109.556933,"median":-44.419762,"eighty":-30.692508,"marketCap":950035452},{"date":"2022-04-08","current":-24.676436,"twenty":-109.221589,"median":-44.205863,"eighty":-29.793308,"marketCap":876827817},{"date":"2022-04-14","current":-23.786774,"twenty":-108.349694,"median":-43.806584,"eighty":-29.251185,"marketCap":845215429},{"date":"2022-04-22","current":-21.195826,"twenty":-106.756809,"median":-43.278965,"eighty":-28.904071,"marketCap":753151281},{"date":"2022-04-29","current":-18.663489,"twenty":-105.423816,"median":-43.036546,"eighty":-28.089583,"marketCap":663169748},{"date":"2022-05-06","current":-17.50679,"twenty":-104.250112,"median":-42.822647,"eighty":-27.285506,"marketCap":622068776},{"date":"2022-05-13","current":-14.044836,"twenty":-102.439254,"median":-42.665788,"eighty":-27.133155,"marketCap":607916686},{"date":"2022-05-20","current":-14.648777,"twenty":-99.681048,"median":-41.92427,"eighty":-26.849087,"marketCap":634057660},{"date":"2022-05-27","current":-16.627647,"twenty":-98.121697,"median":-41.751192,"eighty":-26.443276,"marketCap":719711063},{"date":"2022-06-03","current":-19.287556,"twenty":-97.702517,"median":-41.667591,"eighty":-25.832717,"marketCap":834842585},{"date":"2022-06-10","current":-17.154489,"twenty":-96.973144,"median":-41.420536,"eighty":-25.210077,"marketCap":742514891},{"date":"2022-06-17","current":-18.131074,"twenty":-96.185085,"median":-40.990661,"eighty":-25.044788,"marketCap":784785402},{"date":"2022-06-24","current":-19.595952,"twenty":-95.841357,"median":-40.783473,"eighty":-24.855707,"marketCap":848191168},{"date":"2022-07-01","current":-18.105374,"twenty":-95.380259,"median":-40.655134,"eighty":-24.539794,"marketCap":783673020},{"date":"2022-07-08","current":-21.908916,"twenty":-94.608968,"median":-39.96687,"eighty":-24.200481,"marketCap":948305535},{"date":"2022-07-15","current":-23.695039,"twenty":-93.435263,"median":-39.703609,"eighty":-23.412179,"marketCap":1025616074},{"date":"2022-07-22","current":-25.185616,"twenty":-91.004018,"median":-39.586604,"eighty":-23.430199,"marketCap":1090134222},{"date":"2022-07-29","current":-25.211316,"twenty":-83.961791,"median":-38.901159,"eighty":-23.515142,"marketCap":1091246604},{"date":"2022-08-05","current":-28.179621,"twenty":-83.374939,"median":-38.670067,"eighty":-23.695039,"marketCap":1219726709},{"date":"2022-08-12","current":-27.381487,"twenty":-81.153284,"median":-37.110004,"eighty":-23.695039,"marketCap":1386790181},{"date":"2022-08-19","current":-23.982178,"twenty":-80.231087,"median":-36.719988,"eighty":-23.786774,"marketCap":1214625389},{"date":"2022-08-26","current":-22.299026,"twenty":-79.141219,"median":-36.193467,"eighty":-23.56414,"marketCap":1129378745},{"date":"2022-09-02","current":-23.729155,"twenty":-78.889711,"median":-35.715698,"eighty":-23.430199,"marketCap":1201810534},{"date":"2022-09-09","current":-27.08446,"twenty":-78.889711,"median":-35.091672,"eighty":-23.498153,"marketCap":1371746655},{"date":"2022-09-16","current":-23.971177,"twenty":-77.984281,"median":-34.672405,"eighty":-23.55434,"marketCap":1214068222},{"date":"2022-09-23","current":-15.500408,"twenty":-76.953098,"median":-34.477397,"eighty":-23.151365,"marketCap":785049162},{"date":"2022-09-30","current":-18.393671,"twenty":-76.684823,"median":-34.243388,"eighty":-22.844603,"marketCap":931584243},{"date":"2022-10-07","current":-17.249567,"twenty":-75.86323,"median":-33.999628,"eighty":-22.293133,"marketCap":873638812},{"date":"2022-10-14","current":-17.359577,"twenty":-75.360213,"median":-33.151343,"eighty":-22.005731,"marketCap":879210488},{"date":"2022-10-21","current":-17.194562,"twenty":-75.016486,"median":-32.595571,"eighty":-21.84249,"marketCap":870852974},{"date":"2022-10-28","current":-17.711609,"twenty":-74.51347,"median":-31.454775,"eighty":-21.303916,"marketCap":897039852},{"date":"2022-11-04","current":-15.136782,"twenty":-74.370949,"median":-30.879501,"eighty":-20.900276,"marketCap":863296062},{"date":"2022-11-11","current":-14.931172,"twenty":-74.060755,"median":-30.694244,"eighty":-19.723275,"marketCap":851569531},{"date":"2022-11-18","current":-14.745144,"twenty":-72.97927,"median":-30.192539,"eighty":-19.41378,"marketCap":840959812},{"date":"2022-11-25","current":-14.422043,"twenty":-71.721729,"median":-29.670452,"eighty":-19.268993,"marketCap":822532406},{"date":"2022-12-02","current":-13.707305,"twenty":-69.76835,"median":-29.329188,"eighty":-18.888157,"marketCap":781768750},{"date":"2022-12-09","current":-7.695673,"twenty":-67.479626,"median":-29.031924,"eighty":-18.586365,"marketCap":438907312},{"date":"2022-12-16","current":-8.576857,"twenty":-66.473593,"median":-28.822168,"eighty":-18.277562,"marketCap":489163875},{"date":"2022-12-23","current":-9.330759,"twenty":-66.113099,"median":-28.324897,"eighty":-18.023135,"marketCap":532161156},{"date":"2022-12-30","current":-10.045497,"twenty":-65.844823,"median":-28.154588,"eighty":-17.973069,"marketCap":572924812},{"date":"2023-01-06","current":-9.183895,"twenty":-65.601699,"median":-27.633426,"eighty":-17.716009,"marketCap":523785062},{"date":"2023-01-13","current":-8.811839,"twenty":-64.922627,"median":-27.423465,"eighty":-17.593425,"marketCap":502565625},{"date":"2023-01-20","current":-8.733512,"twenty":-64.889093,"median":-27.301106,"eighty":-17.524592,"marketCap":498098375},{"date":"2023-01-27","current":-8.097101,"twenty":-64.386076,"median":-27.223103,"eighty":-17.359577,"marketCap":461801968},{"date":"2023-02-03","current":-7.842537,"twenty":-64.134568,"median":-27.08446,"eighty":-17.183561,"marketCap":447283406},{"date":"2023-02-10","current":-6.892816,"twenty":-52.248478,"median":-26.981927,"eighty":-17.051549,"marketCap":393118000},{"date":"2023-02-17","current":-7.475377,"twenty":-51.53548,"median":-26.856091,"eighty":-16.886534,"marketCap":426343171},{"date":"2023-02-24","current":-6.726371,"twenty":-51.238873,"median":-26.674276,"eighty":-16.69122,"marketCap":383625093},{"date":"2023-03-03","current":-6.951562,"twenty":-50.731219,"median":-26.498709,"eighty":-16.159906,"marketCap":396468437},{"date":"2023-03-10","current":-6.354315,"twenty":-50.508763,"median":-26.424546,"eighty":-15.47143,"marketCap":362405656},{"date":"2023-03-17","current":-5.721291,"twenty":-50.252084,"median":-25.875202,"eighty":-15.276524,"marketCap":362203462},{"date":"2023-03-24","current":-5.129737,"twenty":-49.784358,"median":-25.72218,"eighty":-15.032998,"marketCap":324753412},{"date":"2023-03-31","current":-5.094421,"twenty":-48.974392,"median":-25.632328,"eighty":-14.62497,"marketCap":322517588},{"date":"2023-04-06","current":-4.807473,"twenty":-48.729121,"median":-25.599325,"eighty":-14.343716,"marketCap":304351520},{"date":"2023-04-14","current":-4.679638,"twenty":-48.597929,"median":-25.445311,"eighty":-14.163054,"marketCap":296258514},{"date":"2023-04-21","current":-4.935694,"twenty":-48.472442,"median":-25.311858,"eighty":-14.01165,"marketCap":312468886},{"date":"2023-04-28","current":-5.71269,"twenty":-48.375474,"median":-25.214522,"eighty":-13.724787,"marketCap":361658979},{"date":"2023-05-05","current":-6.692765,"twenty":-48.101683,"median":-25.201067,"eighty":-13.437076,"marketCap":423705574},{"date":"2023-05-12","current":-5.135342,"twenty":-47.924859,"median":-25.156019,"eighty":-12.610371,"marketCap":356069196},{"date":"2023-05-19","current":-5.629297,"twenty":-47.673884,"median":-24.996935,"eighty":-9.479581,"marketCap":390318535},{"date":"2023-05-26","current":-5.605102,"twenty":-47.462837,"median":-24.902509,"eighty":-9.144731,"marketCap":388640948},{"date":"2023-06-02","current":-4.379238,"twenty":-47.291717,"median":-24.785251,"eighty":-8.913665,"marketCap":303643216},{"date":"2023-06-09","current":-4.508276,"twenty":-47.063558,"median":-24.686839,"eighty":-8.782467,"marketCap":312590345},{"date":"2023-06-16","current":-4.419562,"twenty":-46.903846,"median":-24.512493,"eighty":-8.694348,"marketCap":306439194},{"date":"2023-06-23","current":-4.508276,"twenty":-46.698503,"median":-24.363229,"eighty":-8.482864,"marketCap":312590345},{"date":"2023-06-30","current":-4.693769,"twenty":-46.630055,"median":-24.270625,"eighty":-8.312502,"marketCap":325451845},{"date":"2023-07-07","current":-5.242182,"twenty":-46.219369,"median":-24.200481,"eighty":-8.204801,"marketCap":363477146},{"date":"2023-07-14","current":-5.564777,"twenty":-46.116697,"median":-24.086688,"eighty":-8.010941,"marketCap":385844970},{"date":"2023-07-21","current":-5.758335,"twenty":-45.842906,"median":-23.971177,"eighty":-7.801415,"marketCap":399265665},{"date":"2023-07-28","current":-5.693816,"twenty":-45.614747,"median":-23.757964,"eighty":-7.693715,"marketCap":394792100},{"date":"2023-08-04","current":-6.137385,"twenty":-45.506371,"median":-23.586142,"eighty":-7.022056,"marketCap":425547859},{"date":"2023-08-11","current":-6.048671,"twenty":-45.466443,"median":-23.539641,"eighty":-6.920231,"marketCap":419396707},{"date":"2023-08-18","current":-1.597791,"twenty":-45.301028,"median":-23.412179,"eighty":-6.881067,"marketCap":118675901},{"date":"2023-08-25","current":-1.545033,"twenty":-45.238284,"median":-23.060996,"eighty":-6.818405,"marketCap":114757357},{"date":"2023-09-01","current":-1.869114,"twenty":-45.23258,"median":-22.932929,"eighty":-6.723182,"marketCap":138828413},{"date":"2023-09-08","current":-1.982165,"twenty":-45.181244,"median":-22.321028,"eighty":-6.68217,"marketCap":147225293},{"date":"2023-09-15","current":-2.019849,"twenty":-44.958789,"median":-22.291218,"eighty":-6.567759,"marketCap":150024253},{"date":"2023-09-22","current":-1.812588,"twenty":-44.764853,"median":-22.113896,"eighty":-6.269649,"marketCap":134629973},{"date":"2023-09-29","current":-1.820125,"twenty":-44.650774,"median":-21.978378,"eighty":-6.208739,"marketCap":135189765},{"date":"2023-10-06","current":-1.778673,"twenty":-44.58803,"median":-21.857517,"eighty":-6.16158,"marketCap":132110909},{"date":"2023-10-13","current":-1.635474,"twenty":-44.508174,"median":-21.601439,"eighty":-6.058349,"marketCap":121474861},{"date":"2023-10-20","current":-1.643011,"twenty":-44.411206,"median":-21.195826,"eighty":-5.916407,"marketCap":122034653},{"date":"2023-10-27","current":-1.560107,"twenty":-44.376982,"median":-21.039745,"eighty":-5.88928,"marketCap":115876941},{"date":"2023-11-03","current":-1.57518,"twenty":-44.205863,"median":-20.897841,"eighty":-5.806724,"marketCap":116996525},{"date":"2023-11-10","current":-1.499813,"twenty":-44.205863,"median":-19.91596,"eighty":-5.721291,"marketCap":111398606},{"date":"2023-11-17","current":-1.702607,"twenty":-44.120303,"median":-19.653361,"eighty":-5.669621,"marketCap":123200631},{"date":"2023-11-24","current":-1.718085,"twenty":-43.869328,"median":-19.507566,"eighty":-5.605102,"marketCap":124320637},{"date":"2023-12-01","current":-1.857389,"twenty":-43.509977,"median":-19.287556,"eighty":-5.561551,"marketCap":134400688},{"date":"2023-12-08","current":-1.857389,"twenty":-43.390193,"median":-19.159059,"eighty":-5.507625,"marketCap":134400688},{"date":"2023-12-15","current":-1.996693,"twenty":-43.219074,"median":-18.921719,"eighty":-5.433509,"marketCap":144480740},{"date":"2023-12-22","current":-1.965737,"twenty":-43.087882,"median":-18.799264,"eighty":-5.343671,"marketCap":142240728},{"date":"2023-12-27","current":-2.089563,"twenty":-43.059362,"median":-18.712101,"eighty":-5.287269,"marketCap":151200774},{"date":"2024-01-05","current":-1.981215,"twenty":-43.04225,"median":-18.470678,"eighty":-5.23573,"marketCap":143360734},{"date":"2024-01-12","current":-1.872868,"twenty":-42.945283,"median":-18.384445,"eighty":-5.127971,"marketCap":135520694},{"date":"2024-01-19","current":-1.803215,"twenty":-42.871131,"median":-18.118224,"eighty":-5.094421,"marketCap":130480668},{"date":"2024-01-26","current":-1.826433,"twenty":-42.819795,"median":-18.028275,"eighty":-4.997082,"marketCap":132160677},{"date":"2024-02-02","current":-1.865128,"twenty":-42.774163,"median":-17.98818,"eighty":-4.874809,"marketCap":134960691},{"date":"2024-02-09","current":-1.772259,"twenty":-42.700012,"median":-17.771279,"eighty":-4.788954,"marketCap":128240657},{"date":"2024-02-16","current":-1.965737,"twenty":-42.340661,"median":-17.69647,"eighty":-4.679638,"marketCap":142240728},{"date":"2024-02-23","current":-2.182432,"twenty":-42.055461,"median":-17.629102,"eighty":-4.609731,"marketCap":157920809},{"date":"2024-03-01","current":-2.151476,"twenty":-41.929974,"median":-17.535593,"eighty":-4.582513,"marketCap":155680797},{"date":"2024-03-08","current":-2.20565,"twenty":-41.872934,"median":-17.515691,"eighty":-4.52118,"marketCap":159600817},{"date":"2024-03-15","current":-1.919302,"twenty":-41.803703,"median":-17.359577,"eighty":-4.450209,"marketCap":138880711},{"date":"2024-03-22","current":-2.754499,"twenty":-41.72916,"median":-17.259852,"eighty":-4.389842,"marketCap":184171323},{"date":"2024-03-28","current":-3.303709,"twenty":-41.690407,"median":-17.189062,"eighty":-4.322784,"marketCap":220892599},{"date":"2024-04-05","current":-3.007981,"twenty":-41.637509,"median":-17.154489,"eighty":-3.276671,"marketCap":201119604},{"date":"2024-04-12","current":-3.185418,"twenty":-41.505482,"median":-17.040548,"eighty":-3.178658,"marketCap":212983401},{"date":"2024-04-19","current":-3.16007,"twenty":-41.443422,"median":-16.996544,"eighty":-3.16345,"marketCap":211288573},{"date":"2024-04-26","current":-3.177012,"twenty":-41.30824,"median":-16.75806,"eighty":-3.15331,"marketCap":212421346},{"date":"2024-05-03","current":-3.084067,"twenty":-41.007439,"median":-16.688516,"eighty":-3.126272,"marketCap":206206892},{"date":"2024-05-10","current":-4.592936,"twenty":-40.989151,"median":-16.330983,"eighty":-3.126272,"marketCap":269481336},{"date":"2024-05-17","current":-4.332959,"twenty":-40.943185,"median":-16.036556,"eighty":-3.12966,"marketCap":254227675},{"date":"2024-05-24","current":-3.880405,"twenty":-40.774209,"median":-15.427962,"eighty":-3.143214,"marketCap":227675007},{"date":"2024-05-31","current":-3.899663,"twenty":-40.737151,"median":-15.329679,"eighty":-3.143214,"marketCap":228804907},{"date":"2024-06-07","current":-3.707087,"twenty":-40.669394,"median":-15.166154,"eighty":-3.15162,"marketCap":217505900},{"date":"2024-06-14","current":-3.572284,"twenty":-40.640874,"median":-15.097618,"eighty":-3.16007,"marketCap":209596594},{"date":"2024-06-21","current":-3.254533,"twenty":-40.125072,"median":-14.838158,"eighty":-3.16007,"marketCap":190953231},{"date":"2024-06-28","current":-3.225647,"twenty":-39.949319,"median":-14.648777,"eighty":-3.16007,"marketCap":189258380},{"date":"2024-07-05","current":-3.293048,"twenty":-39.914661,"median":-14.431834,"eighty":-3.148258,"marketCap":193213033},{"date":"2024-07-12","current":-4.198155,"twenty":-39.781908,"median":-14.225479,"eighty":-3.15669,"marketCap":246318370},{"date":"2024-07-19","current":-3.91892,"twenty":-39.684162,"median":-14.173334,"eighty":-3.16007,"marketCap":229934808},{"date":"2024-07-26","current":-5.055118,"twenty":-39.632142,"median":-14.06957,"eighty":-3.170209,"marketCap":296598954},{"date":"2024-08-02","current":-4.56405,"twenty":-39.582704,"median":-13.96187,"eighty":-3.176968,"marketCap":267786484},{"date":"2024-08-09","current":-4.751153,"twenty":-39.23949,"median":-13.761037,"eighty":-3.176994,"marketCap":240071026},{"date":"2024-08-16","current":-4.98647,"twenty":-38.949128,"median":-13.707305,"eighty":-3.182056,"marketCap":251961336},{"date":"2024-08-23","current":-5.479514,"twenty":-38.844407,"median":-13.428264,"eighty":-3.186446,"marketCap":276874367},{"date":"2024-08-30","current":-5.322636,"twenty":-38.771471,"median":-12.963195,"eighty":-3.187132,"marketCap":268947493},{"date":"2024-09-06","current":-5.232992,"twenty":-38.685668,"median":-12.424693,"eighty":-3.189844,"marketCap":264417851},{"date":"2024-09-13","current":-6.207875,"twenty":-38.529661,"median":-9.805619,"eighty":-3.197273,"marketCap":313677708},{"date":"2024-09-20","current":-6.588864,"twenty":-37.905636,"median":-9.330759,"eighty":-3.205697,"marketCap":332928687},{"date":"2024-09-27","current":-5.972558,"twenty":-37.032001,"median":-9.13494,"eighty":-3.210766,"marketCap":301787398},{"date":"2024-10-04","current":-5.602775,"twenty":-36.899395,"median":-8.948912,"eighty":-3.216718,"marketCap":283102625},{"date":"2024-10-11","current":-5.602775,"twenty":-36.751189,"median":-8.846108,"eighty":-3.225647,"marketCap":283102625},{"date":"2024-10-18","current":-6.269505,"twenty":-36.563982,"median":-8.762885,"eighty":-3.229499,"marketCap":316791837},{"date":"2024-10-25","current":-6.095819,"twenty":-36.415776,"median":-8.694348,"eighty":-3.242979,"marketCap":308015656},{"date":"2024-11-01","current":-5.826886,"twenty":-36.092063,"median":-8.576857,"eighty":-3.260685,"marketCap":294426730},{"date":"2024-11-08","current":-6.908907,"twenty":-35.893154,"median":-8.434888,"eighty":-3.276671,"marketCap":330100645},{"date":"2024-11-15","current":-6.873355,"twenty":-35.737148,"median":-8.390829,"eighty":-3.289305,"marketCap":328402014},{"date":"2024-11-22","current":-6.660044,"twenty":-35.421235,"median":-8.297816,"eighty":-3.297312,"marketCap":318210227},{"date":"2024-11-29","current":-7.110367,"twenty":-35.120923,"median":-8.204801,"eighty":-3.308779,"marketCap":339726222},{"date":"2024-12-06","current":-7.596242,"twenty":-34.988318,"median":-8.155847,"eighty":-3.337261,"marketCap":362940847},{"date":"2024-12-13","current":-6.636342,"twenty":-34.750408,"median":-8.062833,"eighty":-3.370079,"marketCap":317077807},{"date":"2024-12-20","current":-7.406632,"twenty":-34.672405,"median":-7.891492,"eighty":-3.375394,"marketCap":353881481},{"date":"2024-12-27","current":-7.406632,"twenty":-34.672405,"median":-7.842537,"eighty":-3.396652,"marketCap":353881481},{"date":"2025-01-03","current":-7.892507,"twenty":-34.531999,"median":-7.833254,"eighty":-3.403412,"marketCap":377096106},{"date":"2025-01-10","current":-5.356476,"twenty":-34.473497,"median":-7.793582,"eighty":-3.407197,"marketCap":255927087},{"date":"2025-01-17","current":-5.996409,"twenty":-34.329191,"median":-7.724792,"eighty":-3.454812,"marketCap":286502447},{"date":"2025-01-24","current":-5.889754,"twenty":-34.243388,"median":-7.69336,"eighty":-3.520288,"marketCap":281406553},{"date":"2025-01-31","current":-5.747547,"twenty":-34.227787,"median":-7.596242,"eighty":-3.595393,"marketCap":274612029},{"date":"2025-02-07","current":-5.083912,"twenty":-34.157584,"median":-7.501437,"eighty":-3.641611,"marketCap":242904248},{"date":"2025-02-14","current":-4.835049,"twenty":-34.017178,"median":-7.454035,"eighty":-3.666646,"marketCap":231013830},{"date":"2025-02-21","current":-5.81865,"twenty":-33.798769,"median":-7.406632,"eighty":-3.6782,"marketCap":278009291},{"date":"2025-02-28","current":-5.759397,"twenty":-33.307349,"median":-7.382931,"eighty":-3.683977,"marketCap":275178239},{"date":"2025-03-07","current":-5.830501,"twenty":-33.049939,"median":-7.311827,"eighty":-3.707087,"marketCap":278575502},{"date":"2025-03-14","current":-5.385747,"twenty":-32.640423,"median":-7.299976,"eighty":-3.724419,"marketCap":267068399},{"date":"2025-03-21","current":-5.322789,"twenty":-32.613122,"median":-7.134068,"eighty":-3.811078,"marketCap":263946452},{"date":"2025-03-28","current":-4.819127,"twenty":-32.433715,"median":-7.103366,"eighty":-3.880405,"marketCap":238970874},{"date":"2025-04-04","current":-3.891932,"twenty":-31.813589,"median":-7.074815,"eighty":-3.88271,"marketCap":192993105},{"date":"2025-04-11","current":-3.308142,"twenty":-31.423574,"median":-7.027621,"eighty":-3.707087,"marketCap":164044139},{"date":"2025-04-17","current":-4.0064,"twenty":-31.298768,"median":-6.946667,"eighty":-3.707087,"marketCap":198669373},{"date":"2025-04-25","current":-4.44185,"twenty":-30.908752,"median":-6.922189,"eighty":-3.720229,"marketCap":220262470},{"date":"2025-05-02","current":-5.323351,"twenty":-30.85025,"median":-6.905757,"eighty":-3.793746,"marketCap":263974352},{"date":"2025-05-09","current":-3.535542,"twenty":-30.830749,"median":-6.883025,"eighty":-3.707087,"marketCap":198690373},{"date":"2025-05-16","current":-3.545643,"twenty":-30.694244,"median":-6.86834,"eighty":-3.658943,"marketCap":199258059},{"date":"2025-05-23","current":-3.909299,"twenty":-30.685562,"median":-6.861504,"eighty":-3.65676,"marketCap":219694783},{"date":"2025-05-30","current":-4.050721,"twenty":-30.3734,"median":-6.82428,"eighty":-3.658506,"marketCap":227642398},{"date":"2025-06-06","current":-4.040619,"twenty":-30.130847,"median":-6.750742,"eighty":-3.674349,"marketCap":227074712},{"date":"2025-06-13","current":-3.949705,"twenty":-29.918113,"median":-6.726371,"eighty":-3.6782,"marketCap":221965530},{"date":"2025-06-20","current":-3.828487,"twenty":-29.629501,"median":-6.692765,"eighty":-3.695532,"marketCap":215153289},{"date":"2025-06-27","current":-3.858791,"twenty":-29.418892,"median":-6.663161,"eighty":-3.707087,"marketCap":216856349},{"date":"2025-07-03","current":-3.808283,"twenty":-29.36429,"median":-6.658071,"eighty":-3.6782,"marketCap":214017916}],"updateTime":1751635252249}}}